Hancock Jaffe Laboratories Inc Aktien im Umlauf
Was ist das Aktien im Umlauf von Hancock Jaffe Laboratories Inc?
Aktien im Umlauf von Hancock Jaffe Laboratories Inc ist 8.685M
Was ist die Definition von Aktien im Umlauf?
Im Umlauf befindliche Aktien sind alle Aktien einer Gesellschaft oder eines finanziellen Vermögenswertes, die von Anlegern genehmigt, ausgegeben und gekauft wurden und von diesen gehalten werden.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Aktien im Umlauf von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Hancock Jaffe Laboratories Inc
Was macht Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Unternehmen mit aktien im umlauf ähnlich Hancock Jaffe Laboratories Inc
- Logic Instrument S.A hat Aktien im Umlauf von 8.647M
- Sportscene hat Aktien im Umlauf von 8.648M
- Exicure Inc hat Aktien im Umlauf von 8.651M
- Athenex Inc hat Aktien im Umlauf von 8.663M
- First Internet Bancorp hat Aktien im Umlauf von 8.668M
- Northern Lion Gold hat Aktien im Umlauf von 8.683M
- Hancock Jaffe Laboratories Inc hat Aktien im Umlauf von 8.685M
- Wereldhave Belgium SCA hat Aktien im Umlauf von 8.692M
- Gravitas One Capital hat Aktien im Umlauf von 8.700M
- OFS Credit hat Aktien im Umlauf von 8.700M
- CoreCard hat Aktien im Umlauf von 8.701M
- MoSys hat Aktien im Umlauf von 8.705M
- Kura Sushi USA hat Aktien im Umlauf von 8.711M